查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1579749

全球膽管支架市場

Biliary Stents
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 93 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計2030年全球膽管支架市場將達到7.978億美元

2023年全球膽管支架市場預估為6.136億美元，預估至2030年將達7.978億美元，2023-2030年分析期間複合年成長率為3.8%。門診手術中心最終用途是本報告分析的細分市場之一，預計複合年成長率為 3.5%，到分析期結束時將達到 3.69 億美元。分析期間，醫院最終用途細分市場的複合年成長率預計為 4.2%。

美國市場預估價值1.66億美元，中國預期複合年成長率為6.3%

預計2023年美國膽道支架市場規模將達1.66億美元。中國作為世界第二大經濟體，預計2030年市場規模將達到1.624億美元，2023-2030年分析期間複合年成長率為6.3%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 2.1% 和 3.1%。在歐洲，德國的複合年成長率預計為 2.5%。

全球膽道支架市場 - 主要趨勢和促進因素總結

什麼是膽管支架？

膽道支架是一種小型管狀裝置，插入膽管以保持其通暢並確保膽汁從肝臟正常流動到腸道。這些支架主要用於治療因膽管癌、胰臟癌、膽結石以及疤痕或發炎引起的良性狹窄等疾病引起的膽管阻塞。膽管阻塞可導致嚴重的併發症，如黃疸、膽汁性肝硬化和危及生命的感染疾病，如膽管炎。膽道支架可透過打開膽汁排放途徑來緩解這些阻塞，從而減輕症狀並預防併發症。支架大致分為兩種：塑膠支架和金屬支架。塑膠支架隨著時間的推移有閉塞的傾向，因此通常用於短期管理，而自膨脹金屬支架（SEMS）具有較大的管腔並且不太可能閉塞，因此它們用於長期管理。根據阻塞的性質，膽道支架可以透過內視鏡或經皮放置，被認為是安寧療護和術前介入的重要工具，可改善患者的治療效果和生活品質。膽道支架可以減輕症狀並改善膽汁流動，已成為治療惡性和良性膽道疾病的基石。

技術進步是否使膽管支架更有效？

最近的技術進步顯著提高了膽管支架的功效、耐用性和安全性，擴大了其應用範圍並改善了患者的治療結果。最顯著的進步之一是覆膜自膨式金屬支架 (CSEMS) 的出現，其設計目的是防止組織浸潤和遷移，這是傳統金屬支架的常見問題。這些支架塗有聚四氟乙烯 (PTFE) 和矽膠等生物相容性材料，可提供有效的屏障，最大限度地減少腫瘤過度生長並延長支架的通暢性。防支架遷移特徵的使用，例如擴口端和錨固機制，進一步降低了支架遷移的風險，這是併發症。此外，隨著時間的推移逐漸溶解的生物分解性支架的引入為良性狹窄提供了一種有前途的解決方案，消除了支架移除手術的需要。支架上塗有化療和抗增生劑，可局部釋放藥物抑制腫瘤生長和疤痕組織形成，延長支架的功能壽命。支架輸送系統的改進也發揮了重要作用，即使在曲折的解剖結構中，新設備也可以實現更精確的放置。這些輸送系統現在在影像引導下具有改進的可推動性、靈活性和可見性，使胃腸病學家和介入放射科醫生能夠更輕鬆地導航複雜的膽管結構。這些技術進步不僅提高了膽道支架的功效和安全性，也擴大了其在惡性和良性膽道疾病治療中的作用。

不斷變化的治療模式和患者人口統計如何影響膽道支架市場？

不斷發展的治療模式、全球人口老化以及膽道和胰臟疾病發病率的增加正在塑造膽道支架市場。由於老化、肥胖和酒精相關肝病等因素導致肝膽癌的盛行率持續上升，對有效膽道減壓解決方案的需求正在迅速增加。這導致了治療策略的轉變，膽道支架在安寧療護和根治性介入中日益發揮核心作用。例如，對於無法手術的膽管癌或胰臟癌患者，膽道置入術可以有效緩解黃疸等症狀，改善患者的生活品質，並有利於化療，現在已成為治療方案的標準部分。此外，微創內視鏡逆行性造影（ERCP）手術的廣泛使用增加了對可以更精確地部署和更少併發症的支架的需求。患者人口統計也影響市場趨勢，因為世界人口老化導致膽管阻塞和相關併發症的盛行率增加。這些人口趨勢推動了對更耐用、更持久的支架選擇的需求，這些支架可以減少可能不適合再次手術的老年患者的再次手術頻率，這激勵著我。此外，人們越來越重視以患者為中心的設計，優先考慮舒適性和易於放置，並為兒科和青少年患者開發專用支架。這種客製化解決方案的趨勢進一步推動創新，並為製造商創造機會，根據臨床表現和患者結果來區分其產品。

推動膽道支架市場快速成長的因素有哪些？

膽道支架市場的成長是由多種因素推動的，例如膽道疾病盛行率的增加、支架設計的技術進步以及微創手術的日益採用。膽道阻塞的盛行率不斷增加，特別是在肝膽胰癌發生率不斷增加的背景下，是主要的促進因素之一，而膽道支架是控制受影響患者症狀和改善生活品質的重要姑息干預措施。自膨脹金屬支架（SEMS）、覆膜支架和生物分解性支架等創新也透過解決支架閉塞和移位等常見併發症來延長支架壽命，減少翻修手術的需要，這極大地促進了市場成長。此外，ERCP 和經皮置入術等微創手術的趨勢表明，與傳統手術方法相比，這些手術具有更快的恢復時間和更低的併發症率，因此，我們正在擴大膽道支架的使用。人們對膽道疾病的認知不斷提高，及早發現，再加上對內視鏡介入的日益偏好，進一步增加了對先進支架置入術的需求。此外，世界人口老化，更容易患上膽管癌、膽結石和其他膽道疾病，這增加了對有效和持久的支架解決方案的需求。最後，醫療保健行業對基於價值的醫學的重視正在推動向提供臨床療效和成本效率的支架的轉變，改善患者的治療效果，同時減輕醫療保健系統的總體負擔。來改善。這些不同的因素正在改變膽道支架市場，隨著對有效膽道引流解決方案的需求持續成長，膽道支架市場可望持續成長。

受訪企業範例（共42例）

  • Blue Belt Technologies
  • Boston Scientific Corporation
  • Brainlab
  • Claron Technology
  • Fiagon
  • GE Healthcare
  • Karl Storz
  • MAKO
  • Medacta International
  • Medtronic plc
  • Micromar
  • OrthAlign
  • Scopis
  • Stryker Corporation

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP17706

Global Biliary Stents Market to Reach US$797.8 Million by 2030

The global market for Biliary Stents estimated at US$613.6 Million in the year 2023, is expected to reach US$797.8 Million by 2030, growing at a CAGR of 3.8% over the analysis period 2023-2030. Ambulatory Surgery Centers End-Use, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$369.0 Million by the end of the analysis period. Growth in the Hospitals End-Use segment is estimated at 4.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$166.0 Million While China is Forecast to Grow at 6.3% CAGR

The Biliary Stents market in the U.S. is estimated at US$166.0 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$162.4 Million by the year 2030 trailing a CAGR of 6.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.1% and 3.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global Biliary Stents Market - Key Trends and Drivers Summarized

What Are Biliary Stents and Why Are They Used?

Biliary stents are small, tubular devices inserted into the bile duct to maintain its patency and ensure the proper flow of bile from the liver to the intestine. These stents are primarily used in the treatment of bile duct obstructions caused by conditions such as cholangiocarcinoma (bile duct cancer), pancreatic cancer, gallstones, or benign strictures due to scarring and inflammation. Obstruction in the bile duct can lead to serious complications, including jaundice, biliary cirrhosis, and life-threatening infections such as cholangitis. Biliary stents help alleviate these blockages by providing a pathway for bile drainage, reducing symptoms, and preventing complications. The stents are categorized into two major types: plastic and metal. Plastic stents are generally used for short-term management due to their tendency to occlude over time, while self-expanding metallic stents (SEMS) are preferred for longer-term solutions because they provide a larger lumen and resist clogging. Biliary stents can be placed endoscopically or percutaneously depending on the nature of the obstruction, and are considered an essential tool in both palliative care and preoperative interventions to improve patient outcomes and quality of life. With their ability to reduce symptoms and improve bile flow, biliary stents have become a cornerstone in the management of malignant and benign biliary diseases.

How Are Technological Advances Making Biliary Stents More Effective?

Recent technological advancements have significantly enhanced the efficacy, durability, and safety of biliary stents, broadening their applications and improving patient outcomes. One of the most noteworthy developments is the advent of covered self-expanding metallic stents (CSEMS), which are designed to prevent tissue ingrowth and migration, common issues with traditional metal stents. These stents are coated with biocompatible materials such as polytetrafluoroethylene (PTFE) or silicone, providing an effective barrier that minimizes tumor overgrowth and prolongs stent patency. The use of anti-migration features, such as flared ends and anchoring mechanisms, has further reduced the risk of stent displacement, a complication that can necessitate repeat interventions. Additionally, the introduction of biodegradable stents, which gradually dissolve over time, offers a promising solution for benign strictures, eliminating the need for stent removal procedures. Another major innovation is the use of drug-eluting stents, which are coated with chemotherapeutic agents or anti-proliferative drugs that release medication locally to inhibit tumor growth or scar tissue formation, thereby extending the functional life of the stent. Improvements in stent delivery systems have also played a crucial role, with newer devices allowing for more precise deployment even in tortuous anatomy. These delivery systems are now equipped with enhanced pushability, flexibility, and visibility under imaging guidance, enabling gastroenterologists and interventional radiologists to navigate complex bile duct anatomy with greater ease. Such technological advancements are not only improving the effectiveness and safety profile of biliary stents but are also expanding their role in the management of both malignant and benign biliary conditions.

How Are Shifting Treatment Paradigms and Patient Demographics Shaping the Biliary Stent Market?

The biliary stent market is being shaped by evolving treatment paradigms, an aging global population, and the increasing incidence of biliary and pancreatic diseases. As the prevalence of hepatobiliary cancers continues to rise, driven by factors such as aging populations, obesity, and alcohol-related liver diseases, the demand for effective biliary decompression solutions is growing rapidly. This has led to a shift in treatment strategies, with biliary stents playing an increasingly central role in both palliative care and curative interventions. For instance, in patients with inoperable cholangiocarcinoma or pancreatic cancer, biliary stenting is now a standard part of the management protocol, as it effectively alleviates jaundice and other symptoms, improving the patient’s quality of life and facilitating chemotherapy. Furthermore, the expanding use of minimally invasive endoscopic retrograde cholangiopancreatography (ERCP) procedures has driven demand for stents that can be deployed with greater precision and fewer complications. Patient demographics are also influencing market trends, as an aging global population leads to a higher prevalence of bile duct obstructions and related complications. This demographic trend has spurred the need for more durable, long-lasting stent options that can reduce the frequency of reinterventions in elderly patients who may not be ideal candidates for repeated procedures. Moreover, there is a growing emphasis on patient-centric designs that prioritize comfort and ease of placement, as well as the development of specialized stents for pediatric and adolescent patients. This trend toward tailored solutions is further driving innovation and creating opportunities for manufacturers to differentiate their products based on clinical performance and patient outcomes.

What Factors Are Driving the Rapid Growth of the Biliary Stent Market?

The growth in the biliary stent market is driven by several factors, including the increasing prevalence of biliary diseases, technological advancements in stent design, and the rising adoption of minimally invasive procedures. The growing incidence of biliary obstructions, particularly in the context of rising hepatobiliary and pancreatic cancers, is one of the primary drivers, as biliary stents are a key palliative intervention for managing symptoms and improving the quality of life in affected patients. Technological innovations, such as the development of self-expanding metal stents (SEMS), covered stents, and biodegradable stents, are also contributing significantly to market growth by addressing common complications like stent occlusion and migration, thereby extending stent longevity and reducing the need for repeat procedures. Additionally, the trend toward minimally invasive techniques, such as ERCP and percutaneous stenting, is expanding the use of biliary stents as these procedures are associated with shorter recovery times and lower complication rates compared to traditional surgical approaches. Increased awareness and early detection of biliary diseases, coupled with a growing preference for endoscopic interventions, are further bolstering the demand for advanced stenting options. Moreover, the aging global population, which is more susceptible to conditions like cholangiocarcinoma, gallstone disease, and other biliary pathologies, is driving the need for effective and durable stenting solutions. Finally, the healthcare industry’s emphasis on value-based care is prompting a shift toward stents that offer both clinical efficacy and cost-efficiency, leading to increased adoption of innovative stent technologies that improve patient outcomes while reducing the overall burden on healthcare systems. These diverse factors are transforming the biliary stent market, positioning it for sustained growth as the demand for effective biliary drainage solutions continues to rise.

Select Competitors (Total 42 Featured) -

  • Blue Belt Technologies
  • Boston Scientific Corporation
  • Brainlab
  • Claron Technology
  • Fiagon
  • GE Healthcare
  • Karl Storz
  • MAKO
  • Medacta International
  • Medtronic plc
  • Micromar
  • OrthAlign
  • Scopis
  • Stryker Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Biliary Stents - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Biliary Diseases Throws the Spotlight on Stenting Solutions
    • Increasing Adoption of Minimally Invasive Procedures Drives Demand for Biliary Stents
    • Technological Innovations in Stent Design Propel Growth with Enhanced Patency Rates
    • Here's the Story: Expanding Geriatric Population Base Sustains Growth in Biliary Stent Adoption
    • Emergence of Metal & Bioabsorbable Stents Expands Addressable Market for Advanced Solutions
    • Here's How Rising Incidence of Pancreatic & Liver Cancers Spurs Demand in Oncology Applications
    • Rising Awareness of Non-Surgical Treatment Options Drives Adoption in High-Risk Patient Groups
    • Shift Toward Personalized Medicine Generates Opportunities for Customized Stent Solutions
    • Growing Preference for Endoscopic Ultrasound-Guided Procedures Expands Stent Utilization
    • Innovations in Coating Materials & Drug-Eluting Technologies Create Niche Growth Potential
    • Improved Imaging Techniques for Diagnosis & Placement Accelerate Adoption in Complex Cases
    • Rising Focus on Reducing Post-Procedural Complications Spurs Innovations in Stent Engineering
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Biliary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Biliary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Biliary Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Biliary Stents Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • JAPAN
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • CHINA
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: China 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • EUROPE
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Biliary Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Biliary Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Biliary Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • FRANCE
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: France 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • GERMANY
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Spain 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Russia 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Biliary Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Biliary Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Biliary Stents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Australia 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • INDIA
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: India 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: South Korea 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Biliary Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Biliary Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Biliary Stents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Argentina 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Brazil 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Mexico 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Latin America 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Biliary Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Biliary Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Biliary Stents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Iran 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Israel 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Saudi Arabia 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: UAE 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of Middle East 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • AFRICA
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Africa 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030

IV. COMPETITION